288 related articles for article (PubMed ID: 31066220)
21. Differences in the expression of SPI-1 genes pathogenicity and epidemiology between the emerging Salmonella enterica serovar Infantis and the model Salmonella enterica serovar Typhimurium.
Aviv G; Cornelius A; Davidovich M; Cohen H; Suwandi A; Galeev A; Steck N; Azriel S; Rokney A; Valinsky L; Rahav G; Grassl GA; Gal-Mor O
J Infect Dis; 2019 Aug; 220(6):1071-1081. PubMed ID: 31062854
[TBL] [Abstract][Full Text] [Related]
22. Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice.
Hapfelmeier S; Ehrbar K; Stecher B; Barthel M; Kremer M; Hardt WD
Infect Immun; 2004 Feb; 72(2):795-809. PubMed ID: 14742523
[TBL] [Abstract][Full Text] [Related]
23. The Type III Secretion System Effector SptP of Salmonella enterica Serovar Typhi.
Johnson R; Byrne A; Berger CN; Klemm E; Crepin VF; Dougan G; Frankel G
J Bacteriol; 2017 Feb; 199(4):. PubMed ID: 27920299
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the expression of Salmonella Type III secretion system factor PrgI, SipA, SipB, SopE2, SpaO, and SptP in cultures and in mice.
Gong H; Su J; Bai Y; Miao L; Kim K; Yang Y; Liu F; Lu S
BMC Microbiol; 2009 Apr; 9():73. PubMed ID: 19371445
[TBL] [Abstract][Full Text] [Related]
25. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
[TBL] [Abstract][Full Text] [Related]
26. A Salmonella type III effector, PipA, works in a different manner than the PipA family effectors GogA and GtgA.
Takemura M; Haneda T; Idei H; Miki T; Okada N
PLoS One; 2021; 16(3):e0248975. PubMed ID: 33735297
[TBL] [Abstract][Full Text] [Related]
27. Tannic Acid Inhibits
Shu J; Liu H; Liu Y; Chen X; Yu Y; Lv Q; Wang J; Deng X; Guo Z; Qiu J
Front Microbiol; 2021; 12():784926. PubMed ID: 35145491
[No Abstract] [Full Text] [Related]
28. Functional characterization of the type III secretion ATPase SsaN encoded by Salmonella pathogenicity island 2.
Yoshida Y; Miki T; Ono S; Haneda T; Ito M; Okada N
PLoS One; 2014; 9(4):e94347. PubMed ID: 24722491
[TBL] [Abstract][Full Text] [Related]
29. Intestinal Long-Chain Fatty Acids Act as a Direct Signal To Modulate Expression of the Salmonella Pathogenicity Island 1 Type III Secretion System.
Golubeva YA; Ellermeier JR; Cott Chubiz JE; Slauch JM
mBio; 2016 Feb; 7(1):e02170-15. PubMed ID: 26884427
[TBL] [Abstract][Full Text] [Related]
30. Topological Analysis of the Type 3 Secretion System Translocon Pore Protein IpaC following Its Native Delivery to the Plasma Membrane during Infection.
Russo BC; Duncan JK; Goldberg MB
mBio; 2019 May; 10(3):. PubMed ID: 31138750
[TBL] [Abstract][Full Text] [Related]
31. The Type III Secretion System Effector SeoC of Salmonella enterica subsp. salamae and S. enterica subsp. arizonae ADP-Ribosylates Src and Inhibits Opsonophagocytosis.
Pollard DJ; Young JC; Covarelli V; Herrera-León S; Connor TR; Fookes M; Walker D; Echeita A; Thomson NR; Berger CN; Frankel G
Infect Immun; 2016 Dec; 84(12):3618-3628. PubMed ID: 27736780
[TBL] [Abstract][Full Text] [Related]
32. The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells.
Steele-Mortimer O; Brumell JH; Knodler LA; Méresse S; Lopez A; Finlay BB
Cell Microbiol; 2002 Jan; 4(1):43-54. PubMed ID: 11856172
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel 5-amido-2-carboxypyrazines as inhibitors of the type three secretion system of Salmonella enterica serovar Typhimurium.
Li Z; Su J; Liu Z; Shen Y; Tang H
Chem Biol Drug Des; 2023 Sep; 102(3):574-579. PubMed ID: 37208982
[TBL] [Abstract][Full Text] [Related]
34. Natural compound sanguinarine chloride targets the type III secretion system of
Zhang Y; Liu Y; Wang T; Deng X; Chu X
Biochem Biophys Rep; 2018 Jul; 14():149-154. PubMed ID: 29761161
[TBL] [Abstract][Full Text] [Related]
35. Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2.
Cherayil BJ; McCormick BA; Bosley J
Infect Immun; 2000 Oct; 68(10):5567-74. PubMed ID: 10992455
[TBL] [Abstract][Full Text] [Related]
36. SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.
Coombes BK; Lowden MJ; Bishop JL; Wickham ME; Brown NF; Duong N; Osborne S; Gal-Mor O; Finlay BB
Infect Immun; 2007 Feb; 75(2):574-80. PubMed ID: 17158898
[TBL] [Abstract][Full Text] [Related]
37. Differences in Host Cell Invasion and Salmonella Pathogenicity Island 1 Expression between Salmonella enterica Serovar Paratyphi A and Nontyphoidal S. Typhimurium.
Elhadad D; Desai P; Grassl GA; McClelland M; Rahav G; Gal-Mor O
Infect Immun; 2016 Apr; 84(4):1150-1165. PubMed ID: 26857569
[TBL] [Abstract][Full Text] [Related]
38. Controlled Activity of the
Klein JA; Grenz JR; Slauch JM; Knodler LA
mBio; 2017 Dec; 8(6):. PubMed ID: 29208746
[TBL] [Abstract][Full Text] [Related]
39. HilE Regulates HilD by Blocking DNA Binding in Salmonella enterica Serovar Typhimurium.
Grenz JR; Cott Chubiz JE; Thaprawat P; Slauch JM
J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378886
[TBL] [Abstract][Full Text] [Related]
40. Mutations in the Salmonella enterica serovar Choleraesuis cAMP-receptor protein gene lead to functional defects in the SPI-1 Type III secretion system.
Chen ZW; Hsuan SL; Liao JW; Chen TH; Wu CM; Lee WC; Lin CC; Liao CM; Yeh KS; Winton JR; Huang C; Chien MS
Vet Res; 2010; 41(1):5. PubMed ID: 19775595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
